首页 > 最新文献

Pain management最新文献

英文 中文
Chronic shoulder pain due to spinal accessory nerve palsies present opportunities for improved care integration. 脊髓附属神经麻痹导致的慢性肩痛为改善护理一体化带来了机遇。
IF 1.4 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.1080/17581869.2024.2400992
Alice L Ye, Sudhakar Tummala, Suchi Shah, Ravi Tummala, Robert Y North, Mazen Zein

Aim: Chronic shoulder pain due to iatrogenic spinal accessory nerve (SAN) injury continues to be under-recognized, resulting in delayed time-to-diagnosis and poorer outcomes. Solutions are needed to improve the management of this condition, which can be challenging as care needs to be coordinated across pain management, neurophysiology, rehabilitation and reconstructive surgery.Cases: We present a series of six patients with shoulder pain refractory to conservative pain treatments to highlight how SAN injuries continued to be missed and treatment delayed, even at advanced care centers. The time to diagnosis of SAN palsy took an average of 21 months and treatment was inconsistent for all patients.Discussion: None of the six cases had initial suspicion of SAN palsy and only one patient received targeted SAN injury care. SAN treatment should be started as early as possible so that patients can be referred for prompt surgical evaluation if they fail conservative management. Integrated care pathways may be a solution for formalizing multidisciplinary team involvement and improving SAN injury outcomes.Conclusion: Systemic processes, such as integrated care pathways, are needed to optimize early recognition and targeted treatment of SAN injury and may be beneficial for other underdiagnosed and undertreated neuropathic pain conditions.

目的:由于先天性脊髓附属神经(SAN)损伤引起的慢性肩痛仍未得到充分认识,导致诊断时间延迟和治疗效果不佳。由于需要协调疼痛管理、神经生理学、康复和重建手术等方面的治疗,因此改善这种病症的管理非常具有挑战性:我们介绍了一组六名肩痛患者的病例,这些患者对保守的疼痛治疗无效,这突显了即使在先进的医疗中心,SAN损伤仍会被漏诊和延误治疗。所有患者确诊SAN麻痹的时间平均为21个月,治疗方法也不一致:讨论:六个病例中没有一个最初怀疑有SAN麻痹,只有一名患者接受了有针对性的SAN损伤治疗。应尽早开始 SAN 治疗,以便在保守治疗失败后及时转诊进行手术评估。综合护理路径可能是使多学科团队参与正规化并改善SAN损伤预后的一种解决方案:结论:综合护理路径等系统流程可优化对 SAN 损伤的早期识别和针对性治疗,对其他诊断不足和治疗不足的神经病理性疼痛病症也大有裨益。
{"title":"Chronic shoulder pain due to spinal accessory nerve palsies present opportunities for improved care integration.","authors":"Alice L Ye, Sudhakar Tummala, Suchi Shah, Ravi Tummala, Robert Y North, Mazen Zein","doi":"10.1080/17581869.2024.2400992","DOIUrl":"10.1080/17581869.2024.2400992","url":null,"abstract":"<p><p><b>Aim:</b> Chronic shoulder pain due to iatrogenic spinal accessory nerve (SAN) injury continues to be under-recognized, resulting in delayed time-to-diagnosis and poorer outcomes. Solutions are needed to improve the management of this condition, which can be challenging as care needs to be coordinated across pain management, neurophysiology, rehabilitation and reconstructive surgery.<b>Cases:</b> We present a series of six patients with shoulder pain refractory to conservative pain treatments to highlight how SAN injuries continued to be missed and treatment delayed, even at advanced care centers. The time to diagnosis of SAN palsy took an average of 21 months and treatment was inconsistent for all patients.<b>Discussion:</b> None of the six cases had initial suspicion of SAN palsy and only one patient received targeted SAN injury care. SAN treatment should be started as early as possible so that patients can be referred for prompt surgical evaluation if they fail conservative management. Integrated care pathways may be a solution for formalizing multidisciplinary team involvement and improving SAN injury outcomes.<b>Conclusion:</b> Systemic processes, such as integrated care pathways, are needed to optimize early recognition and targeted treatment of SAN injury and may be beneficial for other underdiagnosed and undertreated neuropathic pain conditions.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The concentration of platelets in PRP does not affect pain outcomes in lateral epicondylitis: a systematic review and meta-analysis. PRP中的血小板浓度不会影响外侧上髁炎的疼痛疗效:系统综述和荟萃分析。
IF 1.4 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-14 DOI: 10.1080/17581869.2024.2360381
Nicholas Averell, Brandon Goodwin, Seungkyu Park, Seth Spicer, Margaret Wilson, Jessica Mitchell, Nichole Martinez, Meejan Palhang, Jaimy Jabon, Richard Jermyn

Aim: To investigate the analyze the relationship between concentration platelet-dose in platelet-rich plasma (PRP) injections and improvements in pain when treating lateral epicondylitis. Methods: A systematic review was conducted into five medical databases, exploring the difference in pain outcomes based on concentration of PRP. Results: Initial querying of the databases yielded 1408 articles with 20 articles ultimately included. There was no statistical significance between effect sizes of the two treatment groups (high and low platelet concentration; p = 0.976). Conclusion: Both large and small concentrations of platelets depict significant reduction in pain, however, between subgroups there was no significance. It can thus be concluded that concentration of platelets in PRP does not impact overall pain relief.

目的:在治疗外上髁炎时,研究分析富血小板血浆(PRP)注射中血小板剂量浓度与疼痛改善之间的关系。方法:对五项研究进行了系统回顾:对五个医学数据库进行了系统性回顾,探讨不同浓度的血小板丰富血浆对疼痛疗效的影响。结果:数据库的初步查询结果为 1408 篇文章,最终纳入 20 篇文章。两个治疗组(高浓度和低浓度血小板;P = 0.976)的效果大小没有统计学意义。结论:高浓度和低浓度血小板都能显著减轻疼痛,但亚组之间没有显著性差异。因此可以得出结论,血小板在 PRP 中的浓度不会影响整体疼痛缓解效果。
{"title":"The concentration of platelets in PRP does not affect pain outcomes in lateral epicondylitis: a systematic review and meta-analysis.","authors":"Nicholas Averell, Brandon Goodwin, Seungkyu Park, Seth Spicer, Margaret Wilson, Jessica Mitchell, Nichole Martinez, Meejan Palhang, Jaimy Jabon, Richard Jermyn","doi":"10.1080/17581869.2024.2360381","DOIUrl":"10.1080/17581869.2024.2360381","url":null,"abstract":"<p><p><b>Aim:</b> To investigate the analyze the relationship between concentration platelet-dose in platelet-rich plasma (PRP) injections and improvements in pain when treating lateral epicondylitis. <b>Methods:</b> A systematic review was conducted into five medical databases, exploring the difference in pain outcomes based on concentration of PRP. <b>Results:</b> Initial querying of the databases yielded 1408 articles with 20 articles ultimately included. There was no statistical significance between effect sizes of the two treatment groups (high and low platelet concentration; p = 0.976). <b>Conclusion:</b> Both large and small concentrations of platelets depict significant reduction in pain, however, between subgroups there was no significance. It can thus be concluded that concentration of platelets in PRP does not impact overall pain relief.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11229443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141317874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world evidence of durable multi-dimensional improvement after 60-day peripheral nerve stimulation treatment used for shoulder pain. 经过 60 天的外周神经刺激治疗后,肩部疼痛得到持久、多维度改善的真实证据。
IF 1.4 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-07-23 DOI: 10.1080/17581869.2024.2371779
Ali Valimahomed, David Dickerson, Henry Vucetic, Joseph Rutledge, Claire A Zurn, Nathan D Crosby, Joseph W Boggs

Aim: This real-world analysis aims to quantify improvements in multiple health domains in patients who received 60-day peripheral nerve stimulation (PNS) for shoulder pain.Materials & methods: Patients reported percent pain relief and Patient Global Impression of Change in quality of life, physical function and sleep at the end of treatment (EOT), 3 months, and 6 months.Results: Of 768 patients, 80.7% were responders in at least one domain at EOT. In a subset who were followed up, a cumulative 75% continued to respond in at least one domain through 6 months (85% [n = 140/165] at 3 months and 88% [n = 53/60] at 6 months).Conclusion: 60-day PNS used for shoulder pain produced multi-dimensional improvements across health domains at EOT and through 6 months.

目的:这项真实世界分析旨在量化接受为期 60 天的周围神经刺激(PNS)治疗肩部疼痛的患者在多个健康领域的改善情况。材料与方法:患者在治疗结束 (EOT)、3 个月和 6 个月时报告疼痛缓解百分比以及生活质量、身体功能和睡眠方面的 "患者全球印象变化"。结果在 768 名患者中,80.7% 的患者在治疗结束时至少在一个方面做出了反应。在接受随访的一组患者中,累计 75% 的患者在 6 个月内至少在一个方面持续有反应(3 个月时为 85% [n = 140/165] ,6 个月时为 88% [n = 53/60])。结论:60 天 PNS 治疗肩部疼痛可在 EOT 和 6 个月后多方面改善患者的健康状况。
{"title":"Real-world evidence of durable multi-dimensional improvement after 60-day peripheral nerve stimulation treatment used for shoulder pain.","authors":"Ali Valimahomed, David Dickerson, Henry Vucetic, Joseph Rutledge, Claire A Zurn, Nathan D Crosby, Joseph W Boggs","doi":"10.1080/17581869.2024.2371779","DOIUrl":"10.1080/17581869.2024.2371779","url":null,"abstract":"<p><p><b>Aim:</b> This real-world analysis aims to quantify improvements in multiple health domains in patients who received 60-day peripheral nerve stimulation (PNS) for shoulder pain.<b>Materials & methods:</b> Patients reported percent pain relief and Patient Global Impression of Change in quality of life, physical function and sleep at the end of treatment (EOT), 3 months, and 6 months.<b>Results:</b> Of 768 patients, 80.7% were responders in at least one domain at EOT. In a subset who were followed up, a cumulative 75% continued to respond in at least one domain through 6 months (85% [n = 140/165] at 3 months and 88% [n = 53/60] at 6 months).<b>Conclusion:</b> 60-day PNS used for shoulder pain produced multi-dimensional improvements across health domains at EOT and through 6 months.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-guided treatment of medial collateral ligament calcification of the knee with TenJet™: a case report. 超声引导下使用 TenJet™ 治疗膝关节内侧副韧带钙化:病例报告。
IF 1.7 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2024-01-08 DOI: 10.2217/pmt-2023-0087
Michael Dakkak

Calcification of the medial collateral ligament is a rare cause of medial knee pain along with functional impairment. Most cases are asymptomatic but those that are symptomatic typically respond to conservative management. However, in those instances with persistent symptoms that desire further intervention but want to minimize the risks associated with surgery, we present a novel approach for calcium removal with an ultrasound-guided percutaneous needle tenotomy with TenJet™ as a reasonable treatment modality.

内侧副韧带钙化是导致膝关节内侧疼痛和功能障碍的罕见原因。大多数病例没有症状,但有症状的病例通常会接受保守治疗。然而,对于那些症状持续存在、希望进一步干预但又想尽量减少手术风险的病例,我们提出了一种新的钙质清除方法,即在超声引导下使用 TenJet™ 经皮针刺腱切开术,这是一种合理的治疗方式。
{"title":"Ultrasound-guided treatment of medial collateral ligament calcification of the knee with TenJet™: a case report.","authors":"Michael Dakkak","doi":"10.2217/pmt-2023-0087","DOIUrl":"10.2217/pmt-2023-0087","url":null,"abstract":"<p><p>Calcification of the medial collateral ligament is a rare cause of medial knee pain along with functional impairment. Most cases are asymptomatic but those that are symptomatic typically respond to conservative management. However, in those instances with persistent symptoms that desire further intervention but want to minimize the risks associated with surgery, we present a novel approach for calcium removal with an ultrasound-guided percutaneous needle tenotomy with TenJet™ as a reasonable treatment modality.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MR-conditionality failure modes: a comparison across various spinal cord stimulators. 磁共振条件失效模式:各种脊髓刺激器的比较。
IF 1.4 Q4 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.1080/17581869.2024.2400970
Kristy A Fisher, Terrance C Jenkins, Vinita Singh, Rupeng Li, Yawar J Qadri

As spinal cord stimulation (SCS) becomes a staple of chronic pain management, the SCS industry must constantly evolve to ensure safety, convenience and enhanced efficacy. Beyond waveforms and size, MR-conditionality is a key differentiator sought out by physicians and patients when choosing SCS devices. Many common SCS complications, including lead migration, can affect the MR-conditionality. The authors reviewed literature published between 2015 and 2024 using PubMed and Google Scholar databases, as well as US FDA labels for magnetic resonance imaging and technical manuals with further confirmation from local representatives. Through extensive review of the literature and direct extraction from each SCS device company, the authors aimed to investigate the specific terms of MR-conditionality under various circumstances. This article provides a collective reference of the MR-conditionality of the currently available SCS devices under normal conditions, as well as with common failure modes, such as lead migration, lead fracture and battery detachment.

随着脊髓刺激(SCS)成为慢性疼痛治疗的主要手段,SCS 行业必须不断发展,以确保安全性、便利性和更高的疗效。除了波形和尺寸外,磁共振条件也是医生和患者在选择 SCS 设备时的一个关键区别因素。许多常见的 SCS 并发症,包括导线移位,都会影响磁共振条件性。作者利用 PubMed 和 Google Scholar 数据库查阅了 2015 年至 2024 年间发表的文献,以及美国 FDA 的磁共振成像标签和技术手册,并从当地代表处得到进一步确认。通过广泛查阅文献和直接从各 SCS 设备公司提取资料,作者旨在研究各种情况下磁共振条件性的具体术语。本文就目前市面上的 SCS 设备在正常情况下的磁共振条件性以及常见失效模式(如铅迁移、铅断裂和电池脱落)提供了一个集体参考。
{"title":"MR-conditionality failure modes: a comparison across various spinal cord stimulators.","authors":"Kristy A Fisher, Terrance C Jenkins, Vinita Singh, Rupeng Li, Yawar J Qadri","doi":"10.1080/17581869.2024.2400970","DOIUrl":"10.1080/17581869.2024.2400970","url":null,"abstract":"<p><p>As spinal cord stimulation (SCS) becomes a staple of chronic pain management, the SCS industry must constantly evolve to ensure safety, convenience and enhanced efficacy. Beyond waveforms and size, MR-conditionality is a key differentiator sought out by physicians and patients when choosing SCS devices. Many common SCS complications, including lead migration, can affect the MR-conditionality. The authors reviewed literature published between 2015 and 2024 using PubMed and Google Scholar databases, as well as US FDA labels for magnetic resonance imaging and technical manuals with further confirmation from local representatives. Through extensive review of the literature and direct extraction from each SCS device company, the authors aimed to investigate the specific terms of MR-conditionality under various circumstances. This article provides a collective reference of the MR-conditionality of the currently available SCS devices under normal conditions, as well as with common failure modes, such as lead migration, lead fracture and battery detachment.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring new horizons in pain relief: introducing Volume 14 of Pain Management. 探索疼痛缓解的新视野:介绍疼痛管理的第14卷。
IF 1.7 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-12-01 DOI: 10.2217/pmt-2023-0117
Jasmine Hagan

To our readers, welcome to the first issue of Volume 14 of Pain Management. 2023 marked a significant year for the journal, as we received an impact factor of 1.7 and increased the number of issues from 8 to 12. This foreword presents some of our content highlights from 2023, covering our top articles from the year and providing you with an insight into what to expect in the forthcoming year.

我们的读者,欢迎来到《疼痛管理》第14卷的第一期。2023年对杂志来说是重要的一年,因为我们收到了1.7的影响因子,并且将问题的数量从8个增加到12个。这篇前言介绍了我们2023年的一些内容亮点,涵盖了我们今年的热门文章,并为您提供了对即将到来的一年的展望。
{"title":"Exploring new horizons in pain relief: introducing Volume 14 of <i>Pain Management</i>.","authors":"Jasmine Hagan","doi":"10.2217/pmt-2023-0117","DOIUrl":"10.2217/pmt-2023-0117","url":null,"abstract":"<p><p>To our readers, welcome to the first issue of Volume 14 of <i>Pain Management.</i> 2023 marked a significant year for the journal, as we received an impact factor of 1.7 and increased the number of issues from 8 to 12. This foreword presents some of our content highlights from 2023, covering our top articles from the year and providing you with an insight into what to expect in the forthcoming year.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138461620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of non-oncological high-impact chronic pain in Ecuadorian adults in 2022. 2022 年厄瓜多尔成年人非肿瘤性高影响慢性疼痛的流行病学。
IF 1.7 Q2 Medicine Pub Date : 2023-12-01 Epub Date: 2024-01-09 DOI: 10.2217/pmt-2023-0055
Debora B Martineau, Marco Fornasini, Daniela Suárez, Mario Paz, Cinthia Valarezo, Enrique Loor, Marixa Guerrero, Manuel E Baldeon

Background: There are limited data on non-oncological high-impact chronic pain (HICP) in Ecuador; we report the epidemiological characteristics of HICP. Materials & methods: In this cross-sectional study, we included a random sample of adult individuals who had cell phones. Results & conclusion: The weighted prevalence of HICP was 9.0%: 12.3% for women and 5.6% for men (p = 0.001). HICP was more frequently localized in the lower back and affected the economically active population. Nonsteroidal anti-inflammatory drugs were more commonly used; however, 61% of patients indicated that the effectiveness of their management was low. Overall, HICP had a negative impact on daily life activities. The effectiveness of the current treatment was low and should include an integrated approach.

背景:关于厄瓜多尔非肿瘤性高影响慢性疼痛(HICP)的数据有限;我们报告了 HICP 的流行病学特征。材料与方法:在这项横断面研究中,我们对拥有手机的成年人进行了随机抽样。结果与结论:HICP 的加权患病率为 9.0%:女性为 12.3%,男性为 5.6%(P = 0.001)。腰椎间盘突出症更常发生在腰部,并影响经济活跃人群。非甾体类抗炎药物的使用更为普遍,但 61% 的患者表示其治疗效果不佳。总体而言,腰椎间盘突出症对日常生活造成了负面影响。目前的治疗效果不佳,应采取综合方法。
{"title":"Epidemiology of non-oncological high-impact chronic pain in Ecuadorian adults in 2022.","authors":"Debora B Martineau, Marco Fornasini, Daniela Suárez, Mario Paz, Cinthia Valarezo, Enrique Loor, Marixa Guerrero, Manuel E Baldeon","doi":"10.2217/pmt-2023-0055","DOIUrl":"10.2217/pmt-2023-0055","url":null,"abstract":"<p><p><b>Background:</b> There are limited data on non-oncological high-impact chronic pain (HICP) in Ecuador; we report the epidemiological characteristics of HICP. <b>Materials & methods:</b> In this cross-sectional study, we included a random sample of adult individuals who had cell phones. <b>Results & conclusion:</b> The weighted prevalence of HICP was 9.0%: 12.3% for women and 5.6% for men (p = 0.001). HICP was more frequently localized in the lower back and affected the economically active population. Nonsteroidal anti-inflammatory drugs were more commonly used; however, 61% of patients indicated that the effectiveness of their management was low. Overall, HICP had a negative impact on daily life activities. The effectiveness of the current treatment was low and should include an integrated approach.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139404014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aminophylline in pain and migraine. 氨茶碱在疼痛和偏头痛中的作用。
IF 1.7 Q2 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-07 DOI: 10.2217/pmt-2023-0076
Barrie L Phillips, Matthew Cl Phillips

Although the pathogenesis of migraine is not fully understood, accumulating evidence indicates migraine may be driven by impaired brain energy metabolism in the context of pathologically high levels of adenosine. Considerable evidence indicates that aminophylline, an adenosine receptor antagonist, can provide strong therapeutic relief in pain, particularly post-dural headache. Moreover, direct observations from a previously published observational case series have demonstrated a strong therapeutic impact of low-dose aminophylline in patients with severe, unremitting migraine attacks. Although higher doses of aminophylline are associated with an unfavourable adverse effect profile, low doses of aminophylline are associated with minimal adverse effects. Despite this promise, double-blinded randomized trials will be needed to determine the true therapeutic efficacy of low-dose aminophylline in migraine.

尽管偏头痛的发病机制尚不完全清楚,但越来越多的证据表明,在病理性高水平腺苷的背景下,偏头痛可能是由脑能代谢受损驱动的。大量证据表明,氨茶碱,腺苷受体拮抗剂,可以提供强有力的治疗缓解疼痛,特别是硬脑膜后头痛。此外,先前发表的观察性病例系列的直接观察结果表明,低剂量氨茶碱对严重、持续偏头痛发作的患者有很强的治疗作用。虽然高剂量的氨茶碱与不利的不良反应有关,但低剂量的氨茶碱与最小的不良反应有关。尽管前景光明,但仍需要双盲随机试验来确定低剂量氨茶碱对偏头痛的真正治疗效果。
{"title":"Aminophylline in pain and migraine.","authors":"Barrie L Phillips, Matthew Cl Phillips","doi":"10.2217/pmt-2023-0076","DOIUrl":"10.2217/pmt-2023-0076","url":null,"abstract":"<p><p>Although the pathogenesis of migraine is not fully understood, accumulating evidence indicates migraine may be driven by impaired brain energy metabolism in the context of pathologically high levels of adenosine. Considerable evidence indicates that aminophylline, an adenosine receptor antagonist, can provide strong therapeutic relief in pain, particularly post-dural headache. Moreover, direct observations from a previously published observational case series have demonstrated a strong therapeutic impact of low-dose aminophylline in patients with severe, unremitting migraine attacks. Although higher doses of aminophylline are associated with an unfavourable adverse effect profile, low doses of aminophylline are associated with minimal adverse effects. Despite this promise, double-blinded randomized trials will be needed to determine the true therapeutic efficacy of low-dose aminophylline in migraine.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138499107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: use of high-intensity laser therapy for treatment of trigeminal neuralgia. 病例报告:使用高强度激光疗法治疗三叉神经痛。
IF 1.7 Q2 Medicine Pub Date : 2023-12-01 Epub Date: 2024-01-08 DOI: 10.2217/pmt-2023-0112
Diego M Martinez, Billy K Huh, Saba Javed

Trigeminal neuralgia represents a form of chronic facial pain that is characterized by its incapacitating nature. The current therapeutic approaches encompass pharmacological agents with carbamazepine or non-pharmacologic options including utilization of percutaneous rhizotomy, Gamma knife radiosurgery or microvascular decompression may be indicated in certain cases. While the interventions may be effective, medications have negative side effects and procedures are invasive which can pose challenges for patients with various comorbidities. High-intensity laser therapy (HILT) has demonstrated safety and efficacy for many types of chronic pain such as musculoskeletal, autoimmune and neuropathic. Herein, we demonstrate the benefits of HILT therapy in the management of trigeminal neuralgia in a 72 year-old patient with a complex history of facial surgery and radiation who had failed pharmacological treatments and denied any invasive procedures.

三叉神经痛是一种慢性面部疼痛,其特点是使人丧失工作能力。目前的治疗方法包括使用卡马西平等药物或非药物治疗,包括经皮根治术、伽玛刀放射外科手术或微血管减压术。虽然这些干预措施可能有效,但药物会产生负面影响,而且手术具有创伤性,这对患有各种并发症的患者来说是个挑战。高强度激光疗法(HILT)已被证明对肌肉骨骼痛、自身免疫性疼痛和神经性疼痛等多种慢性疼痛具有安全性和有效性。在此,我们展示了高强度激光疗法在治疗三叉神经痛方面的优势,该患者 72 岁,曾接受过面部手术和放射治疗,病史复杂,药物治疗无效,且拒绝接受任何侵入性手术。
{"title":"Case report: use of high-intensity laser therapy for treatment of trigeminal neuralgia.","authors":"Diego M Martinez, Billy K Huh, Saba Javed","doi":"10.2217/pmt-2023-0112","DOIUrl":"10.2217/pmt-2023-0112","url":null,"abstract":"<p><p>Trigeminal neuralgia represents a form of chronic facial pain that is characterized by its incapacitating nature. The current therapeutic approaches encompass pharmacological agents with carbamazepine or non-pharmacologic options including utilization of percutaneous rhizotomy, Gamma knife radiosurgery or microvascular decompression may be indicated in certain cases. While the interventions may be effective, medications have negative side effects and procedures are invasive which can pose challenges for patients with various comorbidities. High-intensity laser therapy (HILT) has demonstrated safety and efficacy for many types of chronic pain such as musculoskeletal, autoimmune and neuropathic. Herein, we demonstrate the benefits of HILT therapy in the management of trigeminal neuralgia in a 72 year-old patient with a complex history of facial surgery and radiation who had failed pharmacological treatments and denied any invasive procedures.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing post-operative analgesia following spinal cord stimulation implant: a comprehensive evaluation of the effectiveness of erector spinae plane block utilizing liposomal bupivacaine. 加强脊髓刺激植入术后镇痛:利用脂质体布比卡因对竖脊平面阻滞效果进行综合评估。
IF 1.7 Q2 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-06 DOI: 10.2217/pmt-2023-0062
Afrin Sagir, Melissa Murphy, Richard Teames, Doug Calenda

Erector spinae plane block (ESPB) is an inter-fascial plane block that provides multi-dermatomal analgesia for treatment of acute pain and chronic neuropathic pain in the trunk. This retrospective case series describes a novel method of treating acute postoperative pain after spinal cord stimulation implant with erector spinae plane block using liposomal bupivacaine. Bilateral erector spinae plane block was administered at L1-L2 intervertebral level in 18 cases prior to performing spinal cord stimulation implant at one interspace above. This study reveals that the block provides effective analgesia as evidenced by low pain scores and less opioid consumption after surgery.

竖脊肌平面阻滞(ESPB)是一种筋膜间平面阻滞,可提供多皮层镇痛,用于治疗躯干急性疼痛和慢性神经病理性疼痛。本回顾性病例系列描述了一种使用脂质体布比卡因进行竖脊肌平面阻滞治疗脊髓刺激植入术后急性疼痛的新方法。在 18 个病例中,在 L1-L2 椎间水平进行了双侧竖脊平面阻滞,然后在上方一个椎间隙进行了脊髓刺激植入术。这项研究表明,阻滞能提供有效的镇痛效果,术后疼痛评分低、阿片类药物用量少就是证明。
{"title":"Enhancing post-operative analgesia following spinal cord stimulation implant: a comprehensive evaluation of the effectiveness of erector spinae plane block utilizing liposomal bupivacaine.","authors":"Afrin Sagir, Melissa Murphy, Richard Teames, Doug Calenda","doi":"10.2217/pmt-2023-0062","DOIUrl":"10.2217/pmt-2023-0062","url":null,"abstract":"<p><p>Erector spinae plane block (ESPB) is an inter-fascial plane block that provides multi-dermatomal analgesia for treatment of acute pain and chronic neuropathic pain in the trunk. This retrospective case series describes a novel method of treating acute postoperative pain after spinal cord stimulation implant with erector spinae plane block using liposomal bupivacaine. Bilateral erector spinae plane block was administered at L1-L2 intervertebral level in 18 cases prior to performing spinal cord stimulation implant at one interspace above. This study reveals that the block provides effective analgesia as evidenced by low pain scores and less opioid consumption after surgery.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138488240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pain management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1